Evidence map›Paper›PMID 40613236›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Low-Background His-Tag-Targeting Probes for Turn-On Fluorescence Detection of Cell Surface Proteins and Their Binding Interactions.

Pragati Kishore Prasad, Suraj Toraskar, Suman Khan, Tom Granot, Yael Fridmann Sirkis, Eliane Hadas Yardeni, Shira Albeck, Tamar Unger, Ekaterina Petrovich-Kopitman, Yoseph Addadi and 9 more

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Pragati Kishore PrasadDepartment of Chemical and Structural Biology, Weizman Institute of Science, Rehovot, 7610001, Israel.
Suraj ToraskarDepartment of Chemical and Structural Biology, Weizman Institute of Science, Rehovot, 7610001, Israel.
Suman KhanDepartment of Biomolecular Sciences, Weizman Institute of Science, Rehovot, 7610001, Israel.
Tom GranotDepartment of Chemical and Structural Biology, Weizman Institute of Science, Rehovot, 7610001, Israel.
Yael Fridmann SirkisLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Eliane Hadas YardeniLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Shira AlbeckLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Tamar UngerLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Ekaterina Petrovich-KopitmanLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Yoseph AddadiLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Rakesh RaigawaliIndian Institute of Science Education and Research, Pune, 411008, India.
Saurabh AnandIndian Institute of Science Education and Research, Pune, 411008, India.
Sharath S VishweshwaraIndian Institute of Science Education and Research, Pune, 411008, India.
Chethan D ShanthamurthyIndian Institute of Science Education and Research, Pune, 411008, India.
Noa Oppenheimer-LowDepartment of Chemical and Structural Biology, Weizman Institute of Science, Rehovot, 7610001, Israel.
Raghavendra KikkeriIndian Institute of Science Education and Research, Pune, 411008, India.
Ori AvinoamDepartment of Biomolecular Sciences, Weizman Institute of Science, Rehovot, 7610001, Israel.
Leila MotieiDepartment of Chemical and Structural Biology, Weizman Institute of Science, Rehovot, 7610001, Israel.
David MarguliesDepartment of Chemical and Structural Biology, Weizman Institute of Science, Rehovot, 7610001, Israel.ORCID 0000-0002-8151-733X

Funding

Israel Science Foundation 304/22Minerva Foundation 714437
6 · The paper itself

Abstract

Turn-on fluorescent probes consisting of dye-ligand conjugates serve as a powerful tool for detecting cell surface proteins (CSPs) and their interactions with binding partners. However, generating such probes from protein-based ligands remains challenging. This challenge became particularly evident during the COVID-19 pandemic, which highlighted the need for assays to evaluate inhibitors of the interaction between the SARS-CoV-2 virus receptor-binding domain (RBD) and the angiotensin-converting enzyme 2 (ACE2) receptor. To sense this interaction in a cellular environment using turn-on probes, a tri-nitrilotriacetic acid (tri-NTA) unit was conjugated to quinoline-based cyanine (QBC) dyes. This design leverages the high affinity of tri-NTA for His-tag, along with the low-background and confinement-sensitive optical responses of QBC dyes, to create probes that fluoresce upon binding to His-tagged proteins on cell surfaces. Herein, it is shown that this approach enables the development of an exceptionally simple cell-based assay with which inhibitors of the RBD-ACE2 interaction can be readily sensed by combining a turn-on probe, His-tagged RBD, ACE2-expressing cells, and recording changes in the probe's emission spectra. The potential of this method is further demonstrated by using such probes to detect lectin binding to cell surface glycans and to image a bacterial CSP under wash-free conditions.

Indexed as

Fluorescent DyesHistidineMembrane ProteinsAngiotensin-Converting Enzyme 2COVID-19FluorescenceHumansNitrilotriacetic AcidProtein BindingSARS-CoV-2Spike Glycoprotein, CoronavirusACE2 protein, humanAngiotensin-Converting Enzyme 2Fluorescent DyesHistidineMembrane ProteinsNitrilotriacetic AcidSpike Glycoprotein, CoronavirusHis‐tag binding probeprotein surface recognitionreceptor‐ligand interactionthiazole orangeturn‐on fluorescent probes

Identifiers

PMID40613236
PMCPMC12372432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.